Chonluten in THP-1 cells: inflammatory markers and proliferation
Evidence level: Cell research: human THP-1 cell line · Publication year: 2022
This overview discusses one original scientific publication on Chonluten. The source is indexed in PubMed, the literature database of the U.S. National Library of Medicine.
What was studied?
Five peptide preparations were compared in a monocyte cell line that can be differentiated into macrophage-like cells in the laboratory. The experiment included stimulation with bacterial lipopolysaccharide.
What did the researchers find?
In this system, Chonluten inhibited TNF production. The study also reported changes in inflammatory and proliferation processes in the peptide preparations examined.
What are the limitations?
THP-1 is a leukemia-derived cell line, not a clinical study group. Nor is this a lung tissue study; conclusions about respiratory diseases are therefore not justified.
Significance for research
The study links Chonluten to concretely measurable immune cell processes and highlights the difference between a cell model and organ activity.
Official source
Original publication via PubMed — PMID 35408963 · DOI: 10.3390/ijms23073607
Research Use Only. This literature summary does not contain treatment or use advice. Research on a molecule is not evidence of the efficacy, safety, or purity of a Peptidera product. PubMed indexing is not product approval.
Related research products
View product specifications and available batch documentation. The studies discussed were not conducted with Peptidera products and do not prove the efficacy of our products. For laboratory research only; not for human or animal consumption.